Given more time, he could have struck a offer, he stated. This article is normally republished with kind authorization from our close friends at The Kaiser Family Foundation. You will see the entire Kaiser Daily Health Plan Report, search the archives, or sign up for email delivery of in-depth coverage of wellness policy developments, debates and discussions. The Daily Health Policy Report is released for Kaisernetwork.org, a free services of The Henry J. Kaiser Family Foundation. Copyright 2009 Advisory Board Organization and Kaiser Family Base.Secondary study objectives were to evaluate long-term platelet responses and the usage of concurrent ITP therapies. About Adult ITP In sufferers with ITP, platelets – bloodstream elements had a need to prevent bleeding – are destroyed by the patient’s very own disease fighting capability. Recent data also claim that low platelet counts in the blood could be caused by the inability of the body’s natural processes to produce platelets. Low platelet counts leave adult ITP patients open to sudden critical bleeding events. The risk for serious bleeding events increases when platelet counts drop to significantly less than 30,000 platelets per microliter; normal counts range from 150,000 to 400,000 platelets per microliter.